RELAIRO Trademark

Trademark Overview

On Wednesday, December 7, 2011, a trademark application was filed for RELAIRO with the United States Patent and Trademark Office. The USPTO has given the RELAIRO trademark a serial number of 85489159. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 10, 2015. This trademark is owned by Glaxo Group Limited. The RELAIRO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, urological, oncological, hepatological, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immunological diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
relairo

General Information

Serial Number85489159
Word MarkRELAIRO
Filing DateWednesday, December 7, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 10, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 15, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, urological, oncological, hepatological, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immunological diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
Translation of Words in MarkThe wording "RELAIRO" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 13, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, August 10, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 10, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 25, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 24, 2014EXTENSION 5 GRANTED
Tuesday, December 2, 2014EXTENSION 5 FILED
Tuesday, December 2, 2014TEAS EXTENSION RECEIVED
Thursday, July 3, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 2, 2014EXTENSION 4 GRANTED
Monday, June 23, 2014EXTENSION 4 FILED
Monday, June 23, 2014TEAS EXTENSION RECEIVED
Thursday, January 16, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 15, 2014EXTENSION 3 GRANTED
Monday, December 16, 2013EXTENSION 3 FILED
Monday, December 16, 2013TEAS EXTENSION RECEIVED
Thursday, August 1, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 31, 2013EXTENSION 2 GRANTED
Monday, July 1, 2013EXTENSION 2 FILED
Friday, July 26, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 1, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 25, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 25, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 27, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 26, 2012EXTENSION 1 GRANTED
Wednesday, December 12, 2012EXTENSION 1 FILED
Wednesday, December 26, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 12, 2012TEAS EXTENSION RECEIVED
Tuesday, July 10, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 15, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 15, 2012PUBLISHED FOR OPPOSITION
Wednesday, April 25, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 12, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 11, 2012ASSIGNED TO LIE
Wednesday, March 21, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 21, 2012EXAMINER'S AMENDMENT ENTERED
Wednesday, March 21, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 21, 2012EXAMINERS AMENDMENT E-MAILED
Wednesday, March 21, 2012EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 14, 2012ASSIGNED TO EXAMINER
Tuesday, December 13, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 10, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

relairo pharmaceutical disorders treatment substances preparations diseases ophthalmological neurological respiratory oncological